EVALUATION OF INFLAMMATORY MARKERS (C REACTIVE PROTEIN & INTERLEUKIN 4) IN TYPE 2 DIABETES MELLITUS

Abstract

Background: India leads the world with the largest number of Diabetic subjects,
hence can be called as Diabetic Capital of World. Type 2 Diabetes Mellitus (T2DM)
is a metabolic disorder resulting from insulin insufficiency or function. The researches
in past decade have revealed a critical link between metabolic disorders and
inflammation which leads to a concept called metaflammation. The linkage of
inflammation and type 2 diabetes mellitus (T2DM) has been extensively investigated
for over a decade